News
-
-
-
COMMUNIQUÉ DE PRESSE
Avec un chiffre d'affaires de 6,3 MEUR, Fermentalg boucle un 1er semestre 2024 historique également marqué par son accord stratégique avec HuvePharma
Fermentalg annonce un chiffre d'affaires en hausse au 1er semestre 2024 et un partenariat stratégique renforcé avec HuvePharma. Objectif annuel relevé à 12 M€ -
COMMUNIQUÉ DE PRESSE
Thanks to sales of EUR6.3 million, Fermentalg closes a historic 1st half-year 2024, also marked by its strategic agreement with HuvePharma
Fermentalg reports strong sales growth in H1 2024, exceeding targets. Partners with HuvePharma for sustainable solutions. Annual sales target raised to €12M. Strategic alliance for a competitive, sustainable supply -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Successful capital increase for a total amount of EUR12.8m, with the support of Fermentalg's industrial partner HuvePharma and Bpifrance, to create the European champion for microalgae fermentation solutions
Fermentalg successfully completes €12.8 million capital increase to support 2024-2026 strategic plan and strengthen its position as a leader in sustainable marine microalgae solutions